In this edition of The Motley Fool's "Ask a Fool" series, Motley Fool One analyst Jason Moser and Motley Fool Stock Advisor analyst Brendan Mathews take a question from a reader who asks: "Many pharma companies went down 30 to 40%. Is it good time to buy pharma stocks? Can you give some good picks on pharma?"

Brendan says he isn't necessarily a fan of the pharmaceutical industry. Picking winners can be very difficult for individual investors, and Warren Buffett has suggested buying a basket in the past (as opposed to individual stocks). However, Brendan does like Valeant Pharmaceutical (NYSE:BHC), which has a very atypical business model. Instead of relying on risky research spending to develop new products, the company grows by acquiring existing products and companies. The company has a great management team and track record. Jason agrees it's a tricky industry, particularly with smaller companies.